Latest Options News

Temas Resources has completed its acquisition of ORF Technologies, gaining full ownership of the patented Regenerative Chloride Leach (RCL) technology that promises significant cost and environmental advantages in critical metals processing.

Conico Ltd has announced an 8-for-1 security consolidation affecting both ordinary shares and options, with a significant adjustment to the option exercise price set to take effect in December 2025.

MRG Metals secures the Corridor South mining licence, completing key permits for its massive 2-billion-tonne heavy mineral sands project, while setting ambitious production goals and expanding rare earth exploration.

Cann Group Limited (ASX, CAN) launches a $2.5 million Share Purchase Plan offering eligible shareholders discounted shares and attaching options, supporting its recent debt restructure and growth ambitions.

Clever Culture Systems reports a cashflow positive quarter, expanding its pharmaceutical customer base and launching a new contact plate analysis module that promises to drive recurring revenues.

NeuroScientific Biopharmaceuticals has secured regulatory approval for initial patient treatments under its Special Access Program for StemSmart™ in Crohn’s disease, alongside key executive appointments and a manufacturing partnership to support upcoming clinical trials.

Decidr AI Industries moves to acquire full ownership of Decidr.ai, launches its unified AI platform DecidrOS, and reports robust Q1 FY26 progress with significant capital raising and expanding partnerships.

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Caravel Minerals has appointed Primero Group as its preferred EPCM firm and secured a $15 million loan to fund its Definitive Feasibility Study, marking significant progress toward a Final Investment Decision for the Caravel Copper Project.

Noxopharm Limited reports growing interest in its Sofra technology with new research collaborations and a safe, well-tolerated HERACLES trial of SOF-SKN. The company also secures funding extensions to support ongoing development.

PhosCo has received a €1 million grant from the European Bank for Reconstruction and Development alongside a $1.1 million investment from its Managing Director, fueling optimisation efforts ahead of the Gasaat Phosphate Project’s bankable feasibility study.

Kingston Resources reported a 10% revenue increase to $15.8 million in Q1 FY26, driven by higher gold and silver output and successful flotation plant commissioning. Underground mining preparations are advancing, setting the stage for a production ramp-up.